Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

tafenoquine

- PMLiVE

US R&D hit in GSK’s latest cost-cutting round

CRO Parexel rumoured to contract “up to 450” GSK employees

- PMLiVE

GSK names drug hunter challenge winners

Competition finds promising projects in anti-infectives, cancer and neurodegenerative diseases

- PMLiVE

GSK’s oncology president joins NuCana board

Paolo Paoletti also has experience in cancer research at Lilly

- PMLiVE

Novartis brings creative malaria campaign to Pinterest

Invites users to create their own mosquito-killing story

- PMLiVE

First trial results positive for GSK Ebola vaccine

ChAd3-EBO is safe and able to stimulate response

- PMLiVE

GSK tops pharma access to medicines table

But corruption and intellectual property issues in developing nations

Novartis building

Novartis to deliver three million malaria treatments in Zambia

Part of Malaria No More’s Power of One campaign

- PMLiVE

GSK first to file IL-5 antagonist for asthma

Mepolizumab submitted as a treatment for severe eosinophilic asthma

- PMLiVE

NICE backs GSK drug for leukaemia

Arzerra on course for NHS use in blood cancer

- PMLiVE

EU boost for GSK’s Ebola vaccine research

And EMA says it' poised to assess possible vaccines or treatments

- PMLiVE

GSK to sell off part of its HIV venture ViiV Healthcare

And sets out new restructure programme as US Seretide sales hit

- PMLiVE

Novartis announces departures of three execs

Follows deals to sell divisions to GSK and Lilly

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links